Daniel Allar

""



Daniel joined TriMed’s Chicago editorial team in 2017 as a Cardiovascular Business writer. He previously worked as a writer for daily newspapers in North Dakota and Indiana.

LATEST ARTICLES BY THIS AUTHOR

Evolocumab therapy not cost-effective in treating atherosclerotic CVD
5 takeaways from ACC's response to MIPS updates
Electrical, mechanical activation of left ventricle strongly correlated
Man vs. machine: A fair match when it comes to cardiac ablation
High platelet reactivity to clopidogrel associated with greater risk of stent thrombosis, MI
Research funds for cardiac arrest—down 63% since 2010—disproportionately low compared to heart disease, stroke
New trial to test transcatheter ventricular enhancement procedure
NASA: Space weather could increase CVD risk in astronauts
New method could predict bleeding risk for stroke patients
Photo of heart-shaped cell in blood clot wins contest